Rhumbline Advisers Amneal Pharmaceuticals, Inc. Call Options Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AMRX
# of Institutions
249Shares Held
145MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$184 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$129 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$123 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$118 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$58.9 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.59B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...